Levitt, M <br/><br/>
Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.  [electronic resource] 

 -  The New England journal of medicine  Apr 1993 
 - 1081-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199304153281503  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Methotrexate--administration & dosage<br/>Metoclopramide--administration & dosage<br/>Middle Aged<br/>Nausea--prevention & control<br/>Ondansetron--administration & dosage<br/>Regression Analysis<br/>Vomiting--chemically induced